Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 198


Healthcare use for acute gastrointestinal illness in two Inuit communities: Rigolet and Iqaluit, Canada.

Harper SL, Edge VL, Ford J, Thomas MK, Pearl D, Shirley J; IHACC; RICG, McEwen SA.

Int J Circumpolar Health. 2015 May 21;74:26290. doi: 10.3402/ijch.v74.26290. eCollection 2015.


Hereditary diffuse gastric cancer: updated clinical guidelines with an emphasis on germline CDH1 mutation carriers.

van der Post RS, Vogelaar IP, Carneiro F, Guilford P, Huntsman D, Hoogerbrugge N, Caldas C, Schreiber KE, Hardwick RH, Ausems MG, Bardram L, Benusiglio PR, Bisseling TM, Blair V, Bleiker E, Boussioutas A, Cats A, Coit D, DeGregorio L, Figueiredo J, Ford JM, Heijkoop E, Hermens R, Humar B, Kaurah P, Keller G, Lai J, Ligtenberg MJ, O'Donovan M, Oliveira C, Pinheiro H, Ragunath K, Rasenberg E, Richardson S, Roviello F, Schackert H, Seruca R, Taylor A, Ter Huurne A, Tischkowitz M, Joe ST, van Dijck B, van Grieken NC, van Hillegersberg R, van Sandick JW, Vehof R, van Krieken JH, Fitzgerald RC.

J Med Genet. 2015 Jun;52(6):361-374. doi: 10.1136/jmedgenet-2015-103094. Epub 2015 May 15. Review.


Differences in Regional Brain Volumes Two Months and One Year after Mild Traumatic Brain Injury.

Zagorchev L, Meyer C, Stehle T, Wenzel F, Young S, Peters J, Weese J, Paulsen KD, Garlinghouse M, Ford J, Roth R, Flashman LA, McAllister T.

J Neurotrauma. 2015 May 13. [Epub ahead of print]


BRCA1: Beyond double-strand break repair.

Alli E, Ford JM.

DNA Repair (Amst). 2015 May 1. pii: S1568-7864(15)00120-2. doi: 10.1016/j.dnarep.2015.04.028. [Epub ahead of print]


Phase II Study of Gemcitabine, Carboplatin, and Iniparib As Neoadjuvant Therapy for Triple-Negative and BRCA1/2 Mutation-Associated Breast Cancer With Assessment of a Tumor-Based Measure of Genomic Instability: PrECOG 0105.

Telli ML, Jensen KC, Vinayak S, Kurian AW, Lipson JA, Flaherty PJ, Timms K, Abkevich V, Schackmann EA, Wapnir IL, Carlson RW, Chang PJ, Sparano JA, Head B, Goldstein LJ, Haley B, Dakhil SR, Reid JE, Hartman AR, Manola J, Ford JM.

J Clin Oncol. 2015 Jun 10;33(17):1895-901. doi: 10.1200/JCO.2014.57.0085. Epub 2015 Apr 6.


Genomic Complexity Profiling Reveals That HORMAD1 Overexpression Contributes to Homologous Recombination Deficiency in Triple-Negative Breast Cancers.

Watkins J, Weekes D, Shah V, Gazinska P, Joshi S, Sidhu B, Gillett C, Pinder S, Vanoli F, Jasin M, Mayrhofer M, Isaksson A, Cheang MC, Mirza H, Frankum J, Lord CJ, Ashworth A, Vinayak S, Ford JM, Telli ML, Grigoriadis A, Tutt AN.

Cancer Discov. 2015 May;5(5):488-505. doi: 10.1158/2159-8290.CD-14-1092. Epub 2015 Mar 13.


Family care map: Sustaining family-centered care in Polytrauma Rehabilitation Centers.

Ford JH 2nd, Wise M, Krahn D, Oliver KA, Hall C, Sayer N.

J Rehabil Res Dev. 2014;51(8):1311-24. doi: 10.1682/JRRD.2014.03.0066.


Stranded Whole Transcriptome RNA-Seq for All RNA Types.

Miller DF, Yan PX, Fang F, Buechlein A, Ford JB, Tang H, Huang TH, Burow ME, Liu Y, Rusch DB, Nephew KP.

Curr Protoc Hum Genet. 2015 Jan 20;84:11.14.1-11.14.23. doi: 10.1002/0471142905.hg1114s84.


Public health adaptation to climate change in Canadian jurisdictions.

Austin SE, Ford JD, Berrang-Ford L, Araos M, Parker S, Fleury MD.

Int J Environ Res Public Health. 2015 Jan 12;12(1):623-51. doi: 10.3390/ijerph120100623.


Single- versus multifraction stereotactic body radiation therapy for pancreatic adenocarcinoma: outcomes and toxicity.

Pollom EL, Alagappan M, von Eyben R, Kunz PL, Fisher GA, Ford JA, Poultsides GA, Visser BC, Norton JA, Kamaya A, Cox VL, Columbo LA, Koong AC, Chang DT.

Int J Radiat Oncol Biol Phys. 2014 Nov 15;90(4):918-25. doi: 10.1016/j.ijrobp.2014.06.066. Epub 2014 Oct 18.


Lived experience of acute gastrointestinal illness in Rigolet, Nunatsiavut: "just suffer through it".

Harper SL, Edge VL, Ford J, Thomas MK; IHACC Research Group; Rigolet Inuit Community Government, McEwen SA.

Soc Sci Med. 2015 Feb;126:86-98. doi: 10.1016/j.socscimed.2014.12.011. Epub 2014 Dec 8.


Next-generation sequencing for hereditary breast and gynecologic cancer risk assessment.

Kurian AW, Kingham KE, Ford JM.

Curr Opin Obstet Gynecol. 2015 Feb;27(1):23-33. doi: 10.1097/GCO.0000000000000141.


Metastatic tumor evolution and organoid modeling implicate TGFBR2 as a cancer driver in diffuse gastric cancer.

Nadauld LD, Garcia S, Natsoulis G, Bell JM, Miotke L, Hopmans ES, Xu H, Pai RK, Palm C, Regan JF, Chen H, Flaherty P, Ootani A, Zhang NR, Ford JM, Kuo CJ, Ji HP.

Genome Biol. 2014 Aug 27;15(8):428. doi: 10.1186/s13059-014-0428-9.


Lynch syndrome screening should be considered for all patients with newly diagnosed endometrial cancer.

Mills AM, Liou S, Ford JM, Berek JS, Pai RK, Longacre TA.

Am J Surg Pathol. 2014 Nov;38(11):1501-9. doi: 10.1097/PAS.0000000000000321.


Parent decision-making around the genetic testing of children for germline TP53 mutations.

Alderfer MA, Zelley K, Lindell RB, Novokmet A, Mai PL, Garber JE, Nathan D, Scollon S, Chun NM, Patenaude AF, Ford JM, Plon SE, Schiffman JD, Diller LR, Savage SA, Malkin D, Ford CA, Nichols KE.

Cancer. 2015 Jan 15;121(2):286-93. doi: 10.1002/cncr.29027. Epub 2014 Sep 15.


Therapeutic targeting of BRCA1-mutated breast cancers with agents that activate DNA repair.

Alli E, Solow-Cordero D, Casey SC, Ford JM.

Cancer Res. 2014 Nov 1;74(21):6205-15. doi: 10.1158/0008-5472.CAN-14-1716. Epub 2014 Sep 12.


What we learned from the Dust Bowl: lessons in science, policy, and adaptation.

McLeman RA, Dupre J, Berrang Ford L, Ford J, Gajewski K, Marchildon G.

Popul Environ. 2014;35:417-440.


Adapting to the effects of climate change on Inuit health.

Ford JD, Willox AC, Chatwood S, Furgal C, Harper S, Mauro I, Pearce T.

Am J Public Health. 2014 Jun;104 Suppl 3:e9-17. doi: 10.2105/AJPH.2013.301724. Epub 2014 Apr 22. Review.


Group-wise evaluation and comparison of white matter fiber strain and maximum principal strain in sports-related concussion.

Ji S, Zhao W, Ford JC, Beckwith JG, Bolander RP, Greenwald RM, Flashman LA, Paulsen KD, McAllister TW.

J Neurotrauma. 2015 Apr 1;32(7):441-54. doi: 10.1089/neu.2013.3268. Epub 2015 Feb 6.


Clinical evaluation of a multiple-gene sequencing panel for hereditary cancer risk assessment.

Kurian AW, Hare EE, Mills MA, Kingham KE, McPherson L, Whittemore AS, McGuire V, Ladabaum U, Kobayashi Y, Lincoln SE, Cargill M, Ford JM.

J Clin Oncol. 2014 Jul 1;32(19):2001-9. doi: 10.1200/JCO.2013.53.6607. Epub 2014 Apr 14.

Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Loading ...
Write to the Help Desk